Dr. Nowakowski on Using Patient Performance Score and Age for MCL Treatment OncLive 1:00 6 years ago 222 Скачать Далее
Dr. Nowakowski on the Potential Role of Immunotherapy in MCL OncLive 1:19 6 years ago 111 Скачать Далее
Dr. Nowakowski on Biological Heterogeneity in Newly Diagnosed Patients With MCL OncLive 0:58 6 years ago 114 Скачать Далее
Prof. Grzegorz Nowakowski | ASH 2017 | Update from diagnosis to treatment Lymphoma Hub 1:56 6 years ago 127 Скачать Далее
Dr. Nowakowski on the Rationale for Reevaluating Enzastaurin in DLBCL OncLive 1:25 3 years ago 97 Скачать Далее
Dr. Goy on Approved Agents in the Treatment Landscape of MCL OncLive 1:21 7 years ago 73 Скачать Далее
Dr. Nowakowski on the Rationale of the ENGINE Trial in DLBCL OncLive 0:59 3 years ago 121 Скачать Далее
Greg Nowakowski | Gene expression profiling in ABC-type DLBCL patients: ROBUST phase III trial Lymphoma Hub 2:02 6 years ago 324 Скачать Далее
Current treatment landscape for relapsed MCL VJHemOnc – Video Journal of Hematology & HemOnc 2:35 3 years ago 67 Скачать Далее
Professor Simon Rule - How MCL affects a patient's lifestyle J&J Innovative Medicine EMEA 0:45 8 years ago 452 Скачать Далее
Unmet Needs Remain in the Diffuse Large B-Cell Lymphoma Treatment Paradigm Targeted Oncology 1:24 3 years ago 718 Скачать Далее
